PMID: 9535125Apr 16, 1998Paper

Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics

Neuroscience Letters
O OhmoriK Abe

Abstract

Catechol-O-methyltransferase (COMT) is an enzyme which inactivates catecholamine neurotransmitters by methylation, and is considered a candidate for involvement in schizophrenia. A functional COMT gene polymorphism influencing the enzyme activities, the high activity (val-108) and the low activity allele (met-108), was recently confirmed. We investigated a genetic association between schizophrenia and the COMT gene polymorphism in 150 Japanese schizophrenics and controls. We detected the low activity met-108 allele more frequently in schizophrenics than in the controls, and found that subjects sharing the met-108 allele (val/met and met/met) are significantly more common in the patients than in the controls. The results suggest that the low activity met-108 allele may be involved in susceptibility for schizophrenia.

References

Apr 1, 1977·Acta Psychiatrica Scandinavica·M KrawieckaM Vaughan
Dec 15, 1992·Biological Psychiatry·T SargentT F Budinger
Apr 24, 1995·American Journal of Medical Genetics·H P ValladaD Collier
Apr 24, 1995·American Journal of Medical Genetics·V K LasseterL Kasch
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·M KarayiorgouV K Lasseter
Oct 9, 1995·American Journal of Medical Genetics·S G SchwabM Ackenheil

❮ Previous
Next ❯

Citations

Apr 11, 2003·Current Psychiatry Reports·Peter McGuffinAlejandro Corsico
Apr 11, 2003·Current Psychiatry Reports·Larry J Seidman, Heidi E Wencel
May 15, 2004·Current Psychiatry Reports·Nigel M Williams, Michael J Owen
May 23, 2001·Psychiatry Research·M de ChaldéeJ Mallet
Nov 14, 2001·Schizophrenia Research·T ArinamiM Toru
Jul 20, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Tae-Won ParkDaehee Kang
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M F EganD R Weinberger
Sep 4, 2003·Human Molecular Genetics·Michael C O'DonovanMichael J Owen
Jun 20, 2008·Schizophrenia Bulletin·Haraldur Magnus HaraldssonHannes Petursson
Oct 20, 2005·Behavioral and Brain Functions : BBF·Birgit FunkeRaju Kucherlapati
May 6, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Ari IlliEsa Leinonen
Jan 31, 2016·Drug Metabolism and Pharmacokinetics·Li WangTian-Bo Jin
Feb 9, 2016·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ryoko HigashiyamaHeii Arai
Oct 12, 2010·European Psychiatry : the Journal of the Association of European Psychiatrists·J VoiseyC P Morris
May 22, 2010·Journal of Psychiatric Research·Javier CostasManuel Arrojo
Mar 31, 2009·Schizophrenia Research·Tomo OkochiNakao Iwata
Oct 11, 2002·Mayo Clinic Proceedings·Janet L SobellCynthia T McMurray
Mar 11, 2008·European Psychiatry : the Journal of the Association of European Psychiatrists·Ruud van WinkelInez Myin-Germeys
Dec 20, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·José María Pelayo-TeránJosé Luis Vázquez-Barquero
Apr 18, 2006·Biological Psychiatry·Richard Paylor, Elizabeth Lindsay
Jun 13, 2003·American Journal of Human Genetics·Nicholas J BrayMichael C O'Donovan
Mar 31, 2017·International Journal of Molecular Sciences·Matea Nikolac PerkovicNela Pivac
Oct 29, 2003·Molecular Psychiatry·M J OwenM C O'Donovan
Mar 10, 2004·Molecular Psychiatry·B J MowryD F Levinson
Aug 12, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert M BilderAnthony A Grace
Apr 23, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·I KremerR P Ebstein
Dec 24, 2002·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Yasuhide IwataNorio Mori
Jun 20, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Toshiya InadaYoshimi Iijima
Jun 20, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ikwunga WonodiGunvant K Thaker
May 26, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ruud van WinkelInez Myin-Germeys
May 6, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hisae OnoKiyoshi Maeda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Michael F EganD R Weinberger
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Tae-Won ParkDaehee Kang
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
I KremerR P Ebstein
© 2022 Meta ULC. All rights reserved